Business - CNBC

1. Thorne is on pace for $650 million in sales as Gen Z fuels a supplement boom — despite subscription fatigue

2. FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market

3. Eli Lilly opposes push to pass Trump's drug pricing deals into law, CEO says

4. Wall Street loses patience with Nike as turnaround drags, China weakness deepens

5. Walmart-owned Sam's Club raises its annual membership fee to $60

6. Tiger Woods won't captain 2027 Ryder Cup team as golf future remains uncertain

7. Visa launches new AI tools to manage the charge dispute process

8. Volkswagen deal with EV maker Xpeng shows how China tech threatens Western automakers

9. Nike shares fall 9% on weak outlook, expected 20% sales decline in China

10. Tom Brady, famed health nut, explains his junk food endorsements in retirement: 'Moderation in all things'

11. Mercedes U.S. CEO sets ambitious sales goal despite 'tougher' market than anticipated

12. 'Project Hail Mary' is the box office proof point Amazon MGM has been waiting for

13. McCormick buys Unilever's food business in deal that values it at nearly $45 billion

14. Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs

15. Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli Lilly

16. Opendoor acquires Doma's closing and escrow business in bid to lower mortgage refinance costs

17. Delta Air Lines taps Amazon Leo for in-flight Wi-Fi as streaming wars heat up

18. JetBlue Airways raises checked bag fees at least $4 as fuel prices soar

19. China suppliers warn of higher prices for Americans due to Strait of Hormuz closure

20. NFL asks prediction market operators to refrain from 'objectionable bets'